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Abstract   
 
Introduction: Endometriosis is associated with an increased risk of dyspareunia, therefore this 
chronic gynaecologic disease should be considered as a major cause of sexual dysfunctions. 
The aims of this study were to review the literature on the effects  of endometriosis surgical 
and pharmacological treatments on female sexual functioning, and to provide suggestions for 
future treatment strategies. Material and methods: We followed the PRISMA guidelines to 
conduct this systematic review, which involved an electronic database search of studies on 
the association between endometriosis and sexuality published between 2000 and 2016. 
Results: As a result of the screening process, 22 studies were included in this systematic 
review. The 22 studies included were divided in 2 categories: 1) surgical intervention studies 
(n = 17), examining postoperative sexual outcomes of surgery for endometriosis; 2) 
pharmacological intervention studies (n = 5), evaluating the effects of pharmacological 
endometriosis treatments on sexual functioning. The studies considered showed that overall 
surgical and pharmacological interventions for endometriosis can lead to medium-/long-term 
improvement, but not necessarily to a definitive resolution of female sexual dysfunctions due 
to endometriosis. Conclusions: Sexual functioning is a multidimensional phenomenon and 
the ideal treatment for endometriosis related sexual dysfunctions should be conducted by a 
multidisciplinary team that involves not only gynaecologists, but also sexologists and 
psychologists/psychotherapists. Improving global sexual functioning, and not just reducing 
pain at intercourse, should be considered as a major clinical goal of endometriosis treatment. 
 
Key-words 
endometriosis, sexual functioning, sexual dysfunction, dyspareunia, female sexuality, sexual 
health. 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Abbreviations 
DIE: deep infiltrating endometriosis 
FSFI: Female Sexual Function Index 
GRADE: Grading of Recommendations Assessment, Development, and Evaluation 
RCT: randomized controlled trial 
 
Key message  
Endometriosis surgical and pharmacological treatments can lead to medium-/long-term 
improvement, but not necessarily to a definitive resolution of female sexual dysfunction. . 
Thus, the ideal treatment should be conducted by a multidisciplinary team, with the aim of 
improving global sexual functioning, and not just reducing pain at intercourse. 
 
Introduction 
Sexual functioning is an important dimension that impacts on women’s physical and 
psychological health, and quality of life (1). Female sexual functioning can be negatively 
affected by a variety of factors, such as operative vaginal delivery (2) and life stressors 
related to medical illness, including infertility (1, 3). Among these stressors, endometriosis—
a chronic gynaecological disease characterized by the presence of endometrial glands and 
stroma outside the uterine cavity—is associated with a ninefold increased risk of dyspareunia 
relative to the general female population (4, 5). Deep dyspareunia (i.e., pain experienced 
inside the vaginal canal, at the level of the cervix, or in the pelvic/uterine/abdominal region, 
associated with sexual intercourse) caused by endometriosis has been frequently linked to 
specific types of lesions, such as those infiltrating the uterosacral ligaments, the pouch of 
Douglas, the posterior vaginal fornix and the anterior rectal wall (1). Pain during intercourse 
can be triggered by traction of scarred and anelastic endometriotic tissue or by mechanical 
pressure on lesions occurring during coitus (1). Dyspareunia is also associated with other 
forms of sexual dysfunctions, such as hypoactive sexual desire, decreased lubrication, arousal 
difficulties, and orgasm disorders due for instance to fear and anticipation of pain, which 
represents one of the most powerful inhibitor of the sexual response cycle (6-8). Several 
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studies have demonstrated the association between pain at intercourse and anxiety, lower 
frequency or even avoidance of intercourse, lower levels of desire and arousal, and poorer 
orgasm (9-11), with negative effects on women’s physical and psychological wellbeing, as 
well as on the couple relationship.  
 
Research investigating the association between endometriosis and global female 
sexual functioning has outlined an even more complex clinical scenario, suggesting that 
dyspareunia is not the unique sexual problem associated with the disease. It was estimated 
that around two thirds of women with endometriosis suffer from some type of sexual 
dysfunction, such as pain at intercourse, low satisfaction, lack of desire, low arousal, orgasm 
difficulties, with a negative impact on women’s psychological health and intimate 
relationships (8, 12-14). Because endometriosis affects from 5% to 10% of women of 
reproductive age (15), it is imaginable that a large proportion of young women in their most 
sexually active period of life present sexual dysfunction caused by the disease, which may 
interfere with conception (5). For this reason, dyspareunia and sexual dysfunctions associated 
with endometriosis represent a major clinical problem as well as an important outcome of 
endometriosis treatments.  However, to our knowledge, there are no published review articles 
on the effects of surgical and pharmacological treatments for endometriosis on female sexual 
functioning.  
 
The aims of the current systematic review are:  1) to describe and compare the 
effectiveness of surgical and pharmacological endometriosis treatments in relation to female 
sexual functioning; 2) to provide suggestions for treatment strategies based on research 
evidence. 
 
Material and methods 
 
The present review was conducted according to the PRISMA guidelines for 
systematic reviews (16) and we ensured compliance by completing the PRISMA checklist. 
We further assessed the quality of evidence of the selected studies using the Grading of 
Recommendations Assessment, Development, and Evaluation (GRADE) criteria (17). Since 
only published data were used, the present study was exempt from Institutional Review 
Board approval. 
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Sources 
An electronic database search (PubMed, Medline) was conducted to identify all 
English-language journal articles published between January 2000 and January 2016 on the 
impact of endometriosis treatments on female sexual functioning. Appropriate search terms 
were constructed by reviewing titles, abstracts, and key-words of a sample of articles 
investigating sexual dysfunctions in patients with endometriosis. Combinations of subject 
heading terms including ‘endometriosis’, ‘rectovaginal endometriosis’, ‘deep infiltrating 
endometriosis’, ‘sexuality’, ‘sexual function’, ‘sexual dysfunction’, ‘dyspareunia’, and 
‘sexual life’ were used. All pertinent papers were retrieved and their reference lists were 
systematically examined to identify additional articles. No attempt was made to identify 
unpublished studies. 
 
Study selection and data extraction 
The present review was designed to provide an overview  on the effects of 
endometriosis surgical and pharmacological treatments on female sexual functioning; thus, 
all published studies evaluating the impact of endometriosis treatments on sexual outcomes 
were included, without any specific restriction regarding the type of endometriotic lesion and 
medical intervention. Two authors (G.B. and F.F) conducted an independent screening of all 
titles and abstracts retrieved from peer-reviewed journals to exclude irrelevant or duplicate 
citations. Because of the paucity of randomized controlled trials (RCTs) on the sexual effects 
of medical interventions in patients with endometriosis, we decided to include all selected 
observational and retrospective studies based on adequacy of description of participants, 
setting, surgical or pharmacological intervention conducted, and sexual outcomes. In order to 
investigate all aspects of female sexual functioning, we included only studies in which sexual 
outcomes were evaluated with a comprehensive sexual questionnaire, focusing not only on 
dyspareunia, but also on other aspects, such as frequency of intercourses, desire, arousal, 
lubrication, sexual satisfaction, orgasm. Exclusion criteria were: qualitative research, case-
report, commentaries or review articles that did not include original data, measurement of 
dyspareunia as unique sexual outcome. 
 
 Two authors (G.B. and F.F.) designed a data extraction form that was applied to each 
paper to independently extract data in relation to author, year of publication, location, setting, 
study design, number of participants, type of endometriosis, sexual functioning questionnaire, 
type of surgical or pharmacological intervention, time to follow-up, principal aims, and 
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outcomes. The quality of evidence of the included studies for the outcome of interest was 
assessed following the criteria described by the GRADE method (17. According to the 
GRADE criteria, the quality of evidence is divided into four categories: high, moderate, low, 
and very low.  
 
Results 
 
A total of 615 articles were identified by database search as potentially relevant. Of 
these 615 articles, 60 had titles or abstracts reporting findings related to the association 
between endometriosis and sexuality, as well as to the assessment of sexual functioning after 
pharmacological or surgical treatment of endometriosis. Overall, 38 articles were not 
included in the current review: 3 studies because the language used was not English (18-20 ); 
11 because they were review articles or commentaries (5, 11, 21-29); 2 because they were 
qualitative studies (30-31); 14 because dyspareunia was the only sexual outcome evaluated, 
no comprehensive sexual questionnaires were used, or no specific information from the 
questionnaires used was reported (1, 32-44); 8 because they were studies on the impact of 
having endometriosis on sexual functioning, without considering the effect of any medical 
intervention (7, 8, 12-14, 45-47). Complete author agreement (G.B. and F.F.) regarding 
included and excluded studies was achieved. Figure 1 shows the flow diagram of the 
literature search results. Because almost all studies included in this review are observational 
studies, the final assessment—according to the GRADE criteria (17)—was low level of 
quality. 
 
Characteristics of studies 
Substantial differences were found in methodology, population, and outcome 
measures of the studies included. The characteristics of the selected studies are extensively 
reported in Table 1 in relation to the following variables: author, year, country, study aims, 
study design, sample, type of endometriosis, sexual functioning measures, time to follow-up. 
Overall, there were 16 prospective observational cohort studies (48-63 ), 2 retrospective 
cohort studies (64, 65), 2 RCT (66, 67), one patients’ preference parallel cohort study (68), 
and one before and after study (69). The number of subjects with endometriosis enrolled in 
the studies ranged from 7 (50) to 250 (60). The most used questionnaire evaluating sexual 
functioning was the Female Sexual Function Index (FSFI). 
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 Seventeen studies examined the effects of surgery for endometriosis on female sexual 
functioning (48-58, 60, 61, 63-65, 68), whereas the impact of pharmacological therapy on 
sexual functioning was assessed in only 5 studies (59, 62, 66, 67, 69). Four studies analysed 
the effects of combined surgical and post-operative pharmacological treatment on sexual 
functioning (52, 55, 60, 68).  
 The main sexual outcomes of the studies included in the review are reported in Table 
2. The heterogeneity of the studies in relation to research methods, types of endometriosis, 
types of treatment, questionnaires used, and sexual outcomes considered did not allow to 
adopt a meta-analytic approach to summarize the results. Thus, we decided to classify the 
studies on the basis of the type of therapeutic intervention performed, so that two  categories 
were identified: 1) surgical intervention and 2) pharmacological intervention studies. 
 
Surgical intervention studies 
We found 17 articles evaluating postoperative sexual outcomes of surgery for endometriosis 
(48-58, 60, 61, 63-65, 68), which was performed at laparoscopy in most of these studies (48-
55, 57, 60, 63, 64, 65). Time to follow-up ranged from 4 (48) to 60 (49) months after surgery 
and participants were mainly patients with deep infiltrating endometriosis (DIE), rectovaginal 
or bowel endometriosis; sexual outcomes were often part of post-operative quality of life 
indicators. Indications for surgery were more frequently persistent pelvic pain or infertility 
rather than sexual complaints. Overall, postoperative global sexual functioning was assessed 
in 1505 women who underwent different types of surgery for endometriosis symptoms.   
 
 Specifically, Garry et al. (48) explored the effects of endometriosis radical 
laparoscopic excision on quality of life indicators, including sexual outcomes. Primary 
indication for surgery was pelvic pain (75.4% of women), whereas dyspareunia was an 
indication for surgery in only 10.5% of cases. The sexual questionnaire used was the Sexual 
Activity Questionnaire that provides separate scores for pleasure, frequency, and discomfort 
with sex. Four months after surgery there was significant improvement on all domains of the 
sexual questionnaire. 
 
Abbott et al. (49) conducted a prospective observational cohort study on 176 women 
with surgical diagnosis of endometriosis. Laparoscopic excision was performed on all 
endometriosis patients with no hormonal pre-treatment and sexual outcomes were evaluated 
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up to 5 years after surgery. The majority of patients (74%) suffered from non-menstrual 
pelvic pain and only 3.5% from dyspareunia; 70% of patients had had one previous surgery. 
Data on revised American Fertility Society (rAFS) stage of endometriosis were recorded 
during surgery (see Table 1); 6% of patients had a full thickness vaginal lesion and 88% of 
women had an involvement of the uterosacral ligaments. Women showed improved sexual 
functioning (pleasure and habit) and decreased discomfort with intercourse at 60 months after 
surgery, although the probability of requiring further surgery was 36%. 
 
Ferrero et al. (51) evaluated deep dyspareunia and quality of sexual life in 68 women 
with endometriosis who underwent laparoscopic full excision of endometriotic lesions. A 
sexual questionnaire based on the DSFI was administered before surgery, and at 6- and 12-
month follow-up. Patients were also asked to rate their overall level of sexual satisfaction on 
a 9-point scale (the Global Sexual Satisfaction Index (GSSI)). At 6- and 12-month follow-up, 
75% of women (either with or without endometriosis of the uterosacral ligaments) reported 
decreased deep dyspareunia. Women with endometriosis of the uterosacral ligaments 
exhibited increased variety in sexual life, higher frequency of intercourse, more satisfying 
orgasms, and were more relaxed and fulfilled after sex. A similar tendency was identified in 
women without endometriotic lesions of the uterosacral ligaments, but statistical significance 
was not always reached. 
 
The impact of laparoscopic radical resection for endometriosis on different sexual 
outcomes (i.e., dyspareunia, sexual function, quality of sex life, and interpersonal 
relationships) was also investigated by Fritzer et al. (63) in a multicentre study on 96 women 
who underwent surgery for endometriosis and concomitant dyspareunia. At 12-month follow-
up women reported decreased pain and improved quality of sex life. No postoperative 
hormonal treatment was administered and the authors concluded that radical laparoscopic 
excision of endometriosis is effective as it leads to improved dyspareunia and quality of 
women’s sexual experience.  
 
Setälä et al. (56) examined sexual functioning in women with deep endometriosis 
nodules of the vagina after surgery, including vaginal resection. Before surgery and at 12-
month follow-up, women’s sexual functioning was evaluated using the McCoy Female 
Sexuality Questionnaire (MFSQ), which assesses sexual satisfaction (sexual enjoyment, 
satisfaction with frequency of intercourse, frequency of sexual thoughts, arousal during sex, 
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frequency of orgasm), sexual problems (poor lubrication, painful sexual intercourse), and 
satisfaction with the partner as a lover and friend. A significant increase in sexual satisfaction 
and decrease in sexual problems was detected at follow-up. No significant differences were 
observed in relation to the satisfaction with the partner. Three patients (14%) reported new-
onset sexual dysfunctions (i.e., decreased libido, decreased vaginal lubrication, dyspareunia). 
 
Che et al. (58) evaluated the sexual functioning of 108 women with DIE by 
comparing 63 participants who underwent conventional surgery (i.e., complete resection of 
all detectable endometriotic lesions with a standard surgical procedure at laparoscopy or 
laparotomy) with 45 patients who underwent nerve-sparing surgery. The Female Sexual 
Function Index (FSFI) was administered at 6-, 12-, and 24-month follow-up, with significant 
improvement in all the FSFI domains and the FSFI total score at the 24-month follow-up 
(except for satisfaction in the conventional surgery group). However, in both groups the total 
FSFI scores at 24-month follow-up were below the cut-off score indicating sexual 
dysfunction. Severe postoperative complications such as bladder dysfunction (self-
catheterization or alteration in voiding symptoms) were also observed in 15.9% of women 
who underwent conventional surgery. 
 
Six studies evaluated the impact of laparoscopic bowel resection for severe 
endometriosis on sexual functioning (50, 53, 54, 57, 64, 65). Meuleman et al. (64) 
retrospectively evaluated sexual function following multidisciplinary CO2 laser radical 
laparoscopic excision of deep infiltrating colorectal endometriosis, with a median 29-month 
follow-up. All 56 procedures were carried out by laparoscopy, and no protective ileostomy 
was needed in this group of patients. When post-operative hormonal contraception was 
desired, a low dose oral contraception or a levonorgestrel-releasing intrauterine device was 
prescribed. No data were provided about the proportion of patients requiring post-surgery 
hormonal treatment. Sexual functioning improved significantly after surgery with respect to 
pleasure, discomfort, and frequency of sexual intercourse. In a similar retrospective study 
published in 2011 (65), the authors confirmed that a radical CO2 laparoscopic excision of 
endometriosis with colorectal wall invasion combined with laparoscopic segmental bowel 
resection and reanastomosis is effective in ameliorating sexual life, in relation to sexual 
pleasure, frequency of sexual activity and discomfort during sexual intercourse.  
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Kössi et al. (54) prospectively evaluated sexual functioning in 26 patients who 
underwent rectal or sigmoid resection for endometriosis. At 12 months after surgery, there 
was a statistically significant improvement in the sexual satisfaction subscale of the McCoy 
Female Sexuality Questionnaire. A numerical decrease, although not statistically significant, 
was detected on the Sexual problems subscale, in particular with regard to “painful sexual 
intercourse”. No differences were found in the partner satisfaction subscale. Two patients 
reported new-onset deep dyspareunia.   
 
Only one study (53) compared the effects of two different surgical techniques (i.e., the 
laparoscopic nerve-sparing approach and the classical laparoscopic approach) on sexual 
functioning in patients with severe deep endometriosis. A total of 126 women were included 
in the research, 61 treated with nerve-sparing radical excision of pelvic endometriosis with 
segmental bowel resection and 65 treated with the classical technique. At 12-month follow-
up, women’s sexual functioning was evaluated in terms of change in frequency of sexual 
intercourse, presence of dyspareunia, vaginal dryness, vaginal blood loss after intercourse, 
use of lubricants, sexual desire, orgasm frequency, and patient’s assessment of 
comprehensive sexual satisfaction, without using any validated sexual questionnaire. No 
group differences were found on frequency of sexual intercourses after surgery and number 
of patients claiming dyspareunia, psychological distress, and vaginal dryness. Patients who 
underwent traditional surgery reported more frequent vaginal bleeding and lowered sexual 
desire. Surprisingly, reduced sexual pleasure/frequency of orgasm was more often exhibited 
by patients treated with the nerve sparing approach relative to those treated with traditional 
surgery. 
 
Van den Broeck et al. (57) compared two surgical procedures (i.e., laparoscopic 
surgery with bowel resection and laparoscopic surgery without bowel resection) performed 
on 203 patients with moderate or severe endometriosis on sexual functioning. Both 
procedures led to improved postoperative sexual functioning relative to preoperative sexual 
functioning. Specifically, women in the bowel resection group showed significantly better 
sexual arousal. No significant differences between the two groups were found in relation to 
sexual desire, orgasm problems, and pain during intercourse. In another study (50), fertility-
sparing laparoscopic surgery with bowel resection for severe endometriosis was associated 
with increased sexual functioning at 12-month follow-up, although full statistical significance 
was not reached due to the small sample size (n = 7).  
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A recent study by Morelli et al. (61) reported preliminary results of a single-
institution experience that involved robotic radical treatment (i.e., the DaVinci system) of 10 
patients suffering from DIE with colorectal involvement. All women (with the exception of 
patients who were trying to conceive) were treated with either a continuous low-dose of oral 
contraceptives or oral progestin for 6 months after surgery Findings revealed worsened sexual 
functioning at one-month follow-up as compared with preoperative sexual functioning, which 
returned comparable with preoperative sexual functioning at 12-month follow-up. A 
statistically significant improvement one year after surgery was observed only as regards 
dyspareunia.  
 
Several authors have investigated the impact of surgical treatments for endometriosis 
and subsequent pharmacological therapies on sexual functioning (52, 55, 60). Ferrero et al. 
(52) examined the effects of laparoscopic excision of endometriosis combined with a 
postoperative 6-month treatment with triptorelin. Main sexual outcome measures were deep 
dyspareunia and quality of sex life. At 12 months after completing the postoperative 
treatment, 45.9% of women did not have deep dyspareunia, 34.7% showed decreased 
dyspareunia, and 62.2% reported increased frequency of sexual intercourse, as well as 
improvements in several aspects of sexual life, such as orgasm and satisfaction.  
 
Mabrouk et al. (55) investigated the impact of laparoscopic full excision of 
endometriosis and subsequent combined oral contraceptive therapy on sexual functioning 
among 106 women with DIE. At 6 months after surgery and subsequent postoperative 
pharmacological treatment, there were improvements in sexual desire, satisfaction with sex, 
and pelvic problem interference with intercourse. No significant pre-postoperative differences 
were found in relation to orgasm between women who underwent intestinal resection and 
those who had intestinal nodule excision.  
 
Di Donato et al. (60) evaluated the impact of laparoscopic surgery for endometriosis 
(with postoperative hormonal treatment) on sexual functioning by comparing 250 patients 
affected by DIE with 250 healthy controls. The DIE group showed improved desire, 
satisfaction, and pelvic problem interference at 6 months after surgery, to the point that these 
scores were comparable to those reported by healthy women (with the exception of orgasm).    
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Vercellini et al. (68) examined the effects of surgical versus low-dose progestin 
treatment on sexual functioning in women with endometriosis and associated severe deep 
dyspareunia. Treatments (laparoscopic surgery or norethisterone acetate 2.5 mg/day per os) 
were not randomly allocated, as the design of the study was a patient preference, parallel 
cohort study with a 12-month follow-up. Findings showed improved sexual function 
immediately after surgery, but the effect declined over time. A more gradual, but progressive 
increase was observed during progestin use and no significant between-group differences 
emerged at 12-month follow-up. The authors concluded that both surgery and low dose 
norethisterone acetate treatment can be considered as valuable strategies for reducing the 
negative effects of deep dyspareunia related to endometriosis on women’s sexual functioning. 
 
Taken together, the above mentioned studies showed that surgery for endometriosis 
may lead to improved sexual functioning, although the extent and the length of these positive 
effects were often poorly defined. Most articles had an exclusive focus on DIE and radical 
laparoscopic surgery (including bowel resection). Although several studies considered of a 
post-operative pharmacological adjuvant therapy, a comparison between surgery and 
hormonal treatment was systematically addressed only in one study (68). 
 
Pharmacological intervention studies 
We found only 5 studies (59, 62, 66, 67, 69) investigating the effects of 
pharmacological treatments for endometriosis on global female sexual functioning. Overall, 
396 women were examined. This paucity of data may seem surprising if one considers the 
huge amount of research evidence for the efficacy of medical treatment for symptomatic 
endometriosis. However, almost all of these studies focused exclusively on the effects of 
treatments on deep dyspareunia, without considering global female sexual functioning. 
Moreover, most studies evaluated the effects of hormonal therapy after surgical treatment for 
endometriosis, and for this reason were included in the “Surgical intervention studies” section 
of this review.  
 
Two of the studies investigating the sexual impact of pharmacological treatment for 
endometriosis are RCTs. The RCT conducted by Vercellini et al. (68) compared the effects of 
cyproterone acetate with continuous monophasic oral contraceptive. Sexual outcomes were 
examined after 6 months of treatment and improved sexual functioning was identified in both 
groups, with no statistically significant differences. The RCT conducted by Guzick et al. (67) 
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compared the efficacy of leuprolide and continuous oral contraceptives with regard to sexual 
satisfaction, with no between-group differences. 
 
Three studies have recently evaluated the efficacy of dienogest, a new progestin 
specifically proposed for the treatment of endometriosis, on sexual functioning. Morotti et al. 
(59) assessed sexual function after 6-months of dienogest treatment in women with 
symptomatic rectovaginal endometriosis, who had pain persistence and were unsatisfied after 
6 months of treatment with norethisterone acetate therapy. Patients treated with dienogest 
exhibited increased lubrication, decreased pain, and overall improved sexual functioning. 
Dienogest was generally well tolerated, with no reported serious adverse effects. 
 
Vercellini et al. (69) assessed sexual functioning in 90 patients with symptomatic 
endometriosis who were treated with norethindrone acetate and 90 who were treated with 
dienogest. After 6 months of therapy, all participants reported increased sexual functioning, 
although with no significant group differences, and the average total FSFI score remained 
below the threshold for sexual dysfunction in both groups. 
 
Caruso et al. (62) investigated quality of life and sexual functioning in 54 women 
affected by endometriosis-associated pelvic pain during a 6-month treatment with 2 mg/daily 
of dienogest. The control group was composed of women with pelvic pain due to 
endometriosis who refused to assume hormonal treatments for different reasons and were 
treated only with non-steroidal anti-inflammatory drugs. Women in the dienogest group 
showed reduced pain symptoms and increased sexual functioning, whereas no significant 
changes were observed in the control condition. 
 
Discussion 
 
The aims of the current review were to describe and compare the effectiveness of 
different treatments of endometriosis in relation to sexual functioning and to suggest useful 
treatment strategies based on research evidence, as well as new avenues for future studies. In 
our systematic review, we adopted a comprehensive approach as we considered multiple 
dimensions of female sexuality, and not just pain at intercourse. Such a wide-ranging 
perspective is consistent with the evidence provided by the research literature, which has 
shown that: a) reduction of pain at intercourse, though important, does not necessarily lead to 
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improved overall sexual functioning (6); b) female sexual function is a multifactorial process 
that involves different psychological dimensions (e.g., personality traits, body image, self-
esteem, relational adjustment) and sexual mechanisms (e.g., interest in sex, desire, arousal, 
pleasure, satisfaction with sex and with partner), which are pivotal for good sexuality.  
 
Overall, the studies examined in this review highlighted that endometriosis, especially 
when associated with deep dyspareunia and/or chronic pelvic pain, has strong negative 
effects on several domains of female sexual functioning, such as desire, orgasm, satisfaction 
with sex, and frequency of sexual intercourses.  Particular types of endometriotic lesions, 
such as DIE and rectovaginal endometriosis, are associated with the poorest sexual 
functioning, perhaps because the women affected suffer from deep dyspareunia more 
frequently than those who have other forms of endometriosis or healthy women (7, 12, 14). 
 
However, several authors (30, 70) have recently suggested that the assessment of 
dyspareunia itself does not allow for a comprehensive and precise evaluation of female 
sexual functioning. Although dyspareunia is perceived as very distressing by many women, 
there may be variability in the way it is experienced, as women may display different coping 
strategies. For example, some women may decide to avoid pain by limiting, or even avoiding, 
sexual intercourses; other women may try to find their own way to deal with the pain during 
sex (for instance, by changing position) for several reasons, such as the importance given to 
sexual intimacy, or the wish for a pregnancy (30). Different coping strategies may lead to 
differences in the psychological impact of dyspareunia, for example as regards mental health, 
self-esteem, feelings of femininity, and sense of guilt toward the partner. These issues have 
been poorly investigated so far and future studies should examine the role of individual 
differences, especially in terms of personality traits and coping strategies, to reach broader 
understanding of sexual dysfunction associated with endometriosis. In this light, 
interdisciplinary research conducted by different cooperating professionals (such as 
gynaecologists, psychologists, and sexologists) may lead to increased knowledge, as well as 
to the development of effective treatment programmes. 
 
Overall, research has shown that surgical and pharmacological interventions are both 
valuable options to ameliorate sexual outcomes in a medium-/long-term period in women 
with endometriosis, although the extent and the duration of the observed positive effects have 
been poorly defined. The reviewed articles focused more on surgical rather than 
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pharmacological treatment, thus limited evidence is available on the efficacy of hormonal 
therapy on endometriosis-related sexual dysfunction. This paucity of data may be due to the 
fact that the types of endometriosis more frequently associated with sexual impairment (i.e., 
DIE and rectovaginal endometriosis) have been historically treated with surgery, although 
some authors have underlined that medical treatments other than surgery may lead to 
substantial relief of pain in women with these forms of endometriosis (23, 33, 70-73).  
 
Overall, heterogeneity of population, instruments, and sexual outcomes considered did 
not allow to pool data and estimate the sexual effects of the interventions evaluated by the 
studies included in this review. However, some conclusions can be drawn from our analysis. 
Surgical treatment may improve sexual functioning in women with endometriosis, 
irrespective of the type of surgery (standard surgical procedure at laparoscopy or laparotomy; 
radical, conservative, or nerve sparing surgery). Postoperative improvement in sexual 
functioning is presumably linked to cessation of pain, especially dyspareunia, due to the 
excision of endometriotic foci. Several studies (11, 14) have shown that this sexual benefit 
appears more evident when the endometriotic lesions are localized in the posterior pelvic 
compartment (i.e., pouch of Douglas, uterosacral ligaments, posterior vaginal fornix, recto 
sigmoid portion of the bowel), thus confirming the hypothesis that pain at intercourse may 
have an organic, mechanistic origin. Future studies with longer follow-up times should 
investigate whether the positive sexual effects of surgery are long-lasting or tend to fade over 
time, which represents an important clinical issue.    
 
It should also be reminded that complete radical excision of DIE frequently involves 
concomitant bowel or parametrial resections and/or vaginal opening; these procedures are 
often associated with a high risk of intra- and postoperative major complications, such as 
ureteral, bladder, or bowel injuries or potential risk of pelvic denervation (1, 14, 63). 
Therefore, this surgery requires high level technical competence and should be performed in 
specialized referred centres for surgical treatment of endometriosis; patients should be 
exhaustively informed about types and incidence of possible complications, and 
gynaecological surgeons should be able to adequately manage bowel or urinary damages or, 
alternatively, they should work in a multidisciplinary team that includes a general and/or 
urological surgeon.  
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Risks and benefits of any surgical procedure must always be considered and clearly 
explained to women in order to obtain a full informed consent. This is important if one 
considers that the expected advantages of surgery may influence women’s choices. For 
example, expectations of pain relief, infertility resolution, or amelioration of sexual health 
may affect patients’ decisions to undergo high risk elective surgery. Moreover, women 
should be informed that, unfortunately, the global effectiveness of surgical treatment of DIE 
is operator-dependent. Overall, in the absence of absolute medical indications, surgery can be 
considered as a good option to improve dyspareunia and global sexual functioning when 
hormonal treatment is not feasible (such as for women who are attempting spontaneous 
conception), or when estro-progestin or progestin treatment is ineffective, contraindicated or 
not tolerated because of side effects. 
 
The evidences (although limited) provided by the studies on the efficacy of different 
hormonal treatments with respect to female sexual functioning suggest that pharmacological 
intervention could be a good option for women who are not seeking conception, or underwent 
multiple surgeries for endometriosis without long-lasting benefit, or refuse surgery due to 
potential complications. Further research is needed in order to investigate the role of 
hormonal therapy, as well as the effects of the various available compounds. 
 
Overall, the generalizability of the results provided by the studies examined in this 
review is limited. In most studies evaluating surgical treatments, the presence of sexual 
dysfunction was not the reason for surgical intervention and sexual functioning was not the 
primary study outcome, which involves limitation in the external validity of the reported 
benefits. The population examined represents another limitation, since several studies 
included only women with deep dyspareunia, while other articles did not provide clear 
information about pain severity or types of endometriotic lesions. In several studies (52, 55, 
60) women underwent a combined surgical and postoperative hormonal treatment, such that 
it was not possible to clearly identify the proportion of variance explained by surgery versus 
hormonal therapy. Furthermore, many studies did not report whether patients underwent a 
pre- or postoperative hormonal treatment, which entails partial understanding of the results. 
More research is necessary to explore in-depth sexual functioning in women with 
endometriosis. Future studies should consider the impact of other dimensions, such as 
infertility, which significantly affects intimate relationships, as well as the role of the partner.        
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Conclusions 
 
Sexual functioning is negatively affected by endometriosis, which means that a large 
proportion of women of reproductive age present sexual dysfunction. The research literature 
on endometriosis, as well as our own clinical practice, undoubtedly indicate that these young 
women very often do not have the chance to experience pleasure associated with sexual 
activity. Furthermore, the extant literature on the effects of surgical and pharmacological 
interventions for endometriosis suggests that medical treatment is indeed useful, but may not 
necessarily lead to long-term, definitive resolution of women’s sexual problems.  
 
Since sexual functioning is a multidimensional phenomenon deriving from the 
interaction of multiple physical/anatomical, psychosocial, and emotional factors (74), and 
considering that endometriosis affects multiple physical and psychological dimensions (75), 
we think that the best treatment programme can be provided by multidisciplinary teams 
composed of gynaecologists, sexologists, and psychologists/psychotherapists.  
 
A more comprehensive perspective not exclusively focused on pain may help rule out 
sexual dysfunction in a more complete and precise manner, with subsequent identification of 
the most appropriate approach to treatment. As demonstrated by several studies (6), different 
types of sexual dysfunction (such as pain during intercourse, hypoactive sexual desire 
disorder, lack of arousal, or lack of orgasm) require different treatment programmes. 
Therefore, comprehensive sexual health assessment should be routinely conducted with all 
women referring to dedicated endometriosis centres and the improvement of sexual 
functioning should be considered as a major therapeutic goal. Sexual questionnaires may be 
effectively used by all gynaecologists during preliminary assessment to outline women’s 
sexological profile, as well as to facilitate patient expression of thoughts, feelings, complaints 
or questions regarding sexual life. This is particularly important if one considers that patients 
may feel embarrassed and therefore reluctant to express any type of feeling or concern 
regarding sexuality to their gynaecologists. At the same time, gynaecologists may be more 
likely to prioritise addressing other endometriosis-related issues, such as pelvic pain and its 
medical treatment, with a general lack of knowledge about sexual medicine that may not 
allow formulating appropriate questions to rule out sexual dysfunction and indicate adequate 
therapeutic options.  
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We believe that gynaecological practice with endometriosis patients may be improved 
by providing gynaecologists with training in sexual medicine . If sexual dysfunction is ruled 
out during preliminary assessment, further investigation should be conducted by 
professionals specialized in sexual counselling and therapy focusing not only on the 
symptoms presented by the patient, but also on the association between sexual problems and 
other important psychological, relational, and cultural dimensions, such as for instance self-
esteem, body image, quality of intimate relationship and dyadic coping strategies, and 
cultural beliefs about femininity and sexuality.  
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Legends 
 
Figure 1. Study selection flow chart. 
 
Table 1. Characteristics of studies included in systematic review of evaluation of sexual 
function after treatments for endometriosis. 
 
Table 2. Interventions and main results of individual studies included in systematic review of 
evaluation of sexual function after treatments for endometriosis. 
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Table 1. Characteristics of studies included in systematic review of evaluation of sexual function after treatments for endometriosis. 
 
Author, 
year 
Country Study aims 
(only regarding 
sexual function) 
Study 
design 
Sample Type of endometriosis  Sexual 
functioning 
measures 
Time to 
follow-
up 
(months) 
Garry et al., 
2000 (48) 
United 
Kingdom 
To evaluate sexual 
outcomes after radical 
laparoscopic excision of 
endometriosis 
Prospective 
study 
57 women with 
endometriosis 
63.2% of women with rAFS 
stage III-IV 
44 women with DIE of 
uterosacral ligaments; 
23 women with ovarian 
endometriosis 
19 women with complete 
obliteration of the pouch of 
Douglas 
34 women with rectovaginal 
endometriosis 
Sexual Activity 
Questionnaire 
4 
Vercellini et 
al., 2002 (66) 
Italy To evaluate the degree of 
satisfaction with medical 
therapy 
RCT 90 women with 
endometriosis 
Women with rAFS stage I-IV SRS Scale 6 
Abbott et al., 
2003 (49) 
United 
Kingdom 
To evaluate sexual 
outcomes after laparoscopic 
excision of endometriosis 
Prospective 
observational 
cohort study 
176 women with 
endometriosis 
14% of women with rAFS stage 
I  
28% of women with rAFS stage 
II  
17% of women with rAFS stage 
III  
41% of women with rAFS stage 
IV  
Sexual Activity 
Questionnaire 
60 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Author, 
year 
Country Study aims 
(only regarding 
sexual function) 
Study 
design 
Sample Type of endometriosis  Sexual 
functioning 
measures 
Time to 
follow-
up 
(months) 
Lyons et al., 
2006 (50) 
Australia To describe the effect of 
fertility-sparing 
laparoscopic excision of 
endometriosis and bowel 
resection on sexual 
outcomes 
Prospective 
observational 
cohort study 
7 women with 
endometriosis 
Severe endometriosis involving 
the bowel 
Sexual Activity 
Questionnaire 
12 
Ferrero et al., 
2007 (51) 
Italy To examine the quality of 
sex life and deep 
dyspareunia in women who 
underwent complete 
laparoscopic excision of 
endometriosis and did not 
receive any post-operative 
medical treatment. 
Observational 
cohort 
prospective 
study 
68 women with 
endometriosis 
59 women with rAFS stage I-II  
9 women with rAFS stage III-
IV  
44 women with endometriosis 
of the uterosacral ligaments 
Sexual Satisfaction 
Subscale  of the 
DSFI; GSSI 
12 
Ferrero et al., 
2007 (52) 2007b 
Italy To evaluate the quality of 
sex life and deep 
dyspareunia after 
laparoscopic full excision of 
endometriosis combined 
with postoperative 
triptorelin treatment for 6 
monthts 
Observational 
cohort study 
98 women with 
endometriosis and 
64 women with 
inclusion of the 
uterosacral 
ligaments  
Not specified 
 
Sexual Satisfaction 
Subscale  of the 
DSFI; GSSI 
12 
Meulemann et 
al., 2009 (43) 
Belgium To evaluate sexual 
outcomes after CO2 
laparoscopic excision of 
colorectal endometriosis 
Retrospective 
cohort study 
56 women with 
endometriosis 
Deep infiltrating colorectal 
endometriosis 
95% of women with rAFS stage 
IV 
Sexual Activity 
Questionnaire 
29 (median 
follow-up 
period) 
Guzick et al., 
2011 (67) 
U.S.A To evaluate sexual 
satisfaction in patients 
underwent leuprolide versus 
OC treatment for 
endometriosis associated 
pain 
RCT 47 women with 
endometriosis 
Not specified 
 
Index of Sexual 
Satisfaction (ISS) 
12 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Author, 
year 
Country Study aims 
(only regarding 
sexual function) 
Study 
design 
Sample Type of endometriosis  Sexual 
functioning 
measures 
Time to 
follow-
up 
(months) 
Meulemann et 
al., 2011 (65) 
Belgium To evaluate sexual 
functioning after CO2 LPS 
excision of colorectal 
endometriosis combined 
with laparoscopic 
segmental bowel resection 
and reanastomosis 
Retrospective 
cohort study 
45 women with 
endometriosis 
DIE with colorectal 
involvement 
Sexual Activity 
Questionnaire 
27 (median 
follow-up 
period) 
Ceccaroni et 
al., 2012 (53) 
Italy To compare laparoscopic 
nerve-sparing approach 
versus classical 
laparoscopic procedure in 
relation to different clinical 
outcomes including 
sexuality 
Prospective 
cohort study 
126 women with 
endometriosis 
DIE Self-report 
questionnaire 
(frequency of 
intercourse, 
dyspareunia, vaginal 
dryness, sexual 
desire, orgasm, 
sexual satisfaction) 
12 
Kössi et al., 
2012 (54) 
Finland Evaluation of sexual 
functioning after 
rectosigmoid resection for 
endometriosis 
Prospective 
study 
26 women with 
endometriosis 
Colorectal endometriosis MFSQ 12 
Mabrouk et 
al., 2012 (55) 
Italy To evaluate the impact of 
the laparoscopic full 
excision of DIE (intestinal 
resection or nodule 
excision) and postoperative 
combined oral 
contraceptives 
administration on sexual 
functioning 
Prospective 
cohort study 
106 women with 
endometriosis 
DIE SHOW-Q 6 
Setälä et al., 
2012 (56) 
Finland To evaluate sexual 
functioning after surgery for 
endometriosis, including 
vaginal resection 
Prospective 
observational 
study 
22 women with 
endometriosis 
Rectovaginal endometriosis MFSQ 12 
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Author, 
year 
Country Study aims 
(only regarding 
sexual function) 
Study 
design 
Sample Type of endometriosis  Sexual 
functioning 
measures 
Time to 
follow-
up 
(months) 
Van den 
Broeck et al., 
2013 (57) 
Belgium To rule out differences in 
sexual functioning in   
women with endometriosis 
who underwent 
laparoscopic surgery with 
versus without bowel 
resection 
Prospective 
cohort study 
203 women with 
endometriosis 
Women with rAFS stage III-IV SSFS 18 
Vercellini et 
al., 2013 (68) 
Italy To estimate the effect of 
surgical versus low-dose 
progestin treatment on 
sexual functioning 
Patients 
preference, 
parallel cohort 
study 
154 women with 
endometriosis 
Women with rAFS stage III-IV 
55 women with ovarian 
endometriosis and 59 with 
rectovaginal endometriosis 
FSFI 12 
 
Che at al., 
2014 (58) 
China To investigate the efficacy 
of nerve-sparing surgery for 
DIE on sexual functioning 
Prospective 
study 
108 women with 
endometriosis 
DIE FSFI 24 
Morotti et al., 
2014 (59) 
Italy To evaluated changes in 
sexual functioning at 6-
months dienogest treatment 
in women who were 
unsatisfied after 6-months 
of norethisterone acetate 
therapy. 
Prospective 
study 
25 women with 
endometriosis  
Rectovaginal endometriosis FSFI 6 
Di Donato et 
al., 2015 (60) 
Italy To evaluate the impact of 
laparoscopic excision on 
endometriosis on sexual 
functioning in women with 
DIE compared with healthy 
women 
Prospective 
study 
250 women with 
endometriosis and 
250 healthy controls 
DIE SHOW-Q 6 
Caruso et al., 
2015 (62) 
Italy To evaluate sexual 
functioning and quality of 
life in women with 
symptomatic endometriosis 
Prospective 
study 
54 women with 
endometriosis and 
48women with 
endometriosis  who 
Symptomatic endometriosis FSFI, FSDS  
6 
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and treated with dienogest refused to take use 
of dienogest 
Morelli et al., 
2016 (61) 
Italy To evaluate sexual 
functioning after robot-
assisted surgery for radical 
treatment of DIE with 
colorectal involvement 
Prospective 
study 
10 women with 
endometriosis 
DIE with recto-sigmoid colon 
involvement 
FSFI 12 
Vercellini et 
al., 2016 (69) 
Italy To evaluate sexual 
functioning after six months 
of dienogest therapy versus 
sexual functioning observed 
during previous 
noretisterone acetate 
therapy 
Before and 
after study 
90 women with 
endometriosis 
Symptomatic endometriosis FSFI 6 
Fritzer et al., 
2016 (63) 
Austria 
and 
Germany 
To evaluate the effect of 
LPS radical resection of 
endometriosis on quality of 
sex life and dyspareunia 
Prospective 
study 
96 women with 
endometriosis 
Patients with histological 
proven endometriosis and 
dyspareunia lasting for at least 6 
months 
FSFI, FSDS 12 
 
Abbreviations: rAFS, revised American Fertility Society; DIE, deep infiltrating endometriosis; RCT, randomized controlled trial; SRS Scale, revised Sabbatsberg Sexual 
Self-Rating Scale; GSSI, Global Sexual Satisfaction Index; MFSQ, McCoy Female Sexuality Questionnaire; SHOW-Q, Sexual health Outcomes in Women Questionnaire; 
FSDS, Female Sexual Distress Scale; SSFS, Short Sexual Functioning Scale; FSFI, Female Sexual Function Index. 
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Table 2. Interventions and main results of individual studies included in systematic review of evaluation of sexual function after treatments for endometriosis. 
 
Author, year Type of surgical 
intervention 
Type of pharmacological 
intervention 
Results (Only sexual outcomes) 
Garry et al., 2000 (48) Radical laparoscopic 
excision of all detected 
endometriosis 
// Four months after surgery all domains of the questionnaire (habit,pleasure, and discomfort 
with sex) significantly improved. 
 
Vercellini et al., 2002 (66) // Low-dose cyproterone 
acetate versus continuous 
monophasic oral 
contraceptive 
A significant improvement in sexual function was observed in both the cyproterone acetate 
arm and the oral contraceptive arm; there were no significant differences between the two 
groups. 
Abbott et al., 2003 (49) Laparoscopic excision 
of endometriosis 
// There is a significant improvement in pleasure and habit, and a decrease in discomfort with 
intercourse that is maintained up to 5 years.. 
Lyons et al, 2006 (50) Fertility-paring 
laparoscopic surgery 
with bowel resection 
// Sexual outcomes improved 12 months after surgery, although measurements did not reach 
statistical significance 
Ferrero et al., 2007 (51) Complete laparoscopic 
excision of all visible 
endometriotic lesions 
// 12 months after surgery patients with endometriosis of the uterosacral ligaments reported 
increased variety in sex life, increased frequency of intercourse, more satisfying orgasms and 
being more relaxed and fulfilled after sex. Similar improvements were observed among 
women with endometriosis but no involvement of uterosacral ligaments; however for some 
variables statistical significance was not reached. 
Ferrero et al., 2007 (52) Complete laparoscopic 
excision of 
endometriosis 
Postoperative triptorelin 
treatment for 6 monthts 
12 months after surgery, 45.9% of patients had no deep dyspareunia, and 34.7% reported a 
decrease in deep dyspareunia intensity. 62.2% of women reported an increase in the frequency 
of sexual intercourse. Improvements in achieving orgasm and global sexual satisfaction were 
reported. 
Meulemann et al.,2009 Radical  laser CO2 // Sexual function improved significantly following surgery with respect to pleasure, discomfort 
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Author, year Type of surgical 
intervention 
Type of pharmacological 
intervention 
Results (Only sexual outcomes) 
(64) laparoscopic excision 
of deep infiltrating 
colorectal 
endometriosis, with 
active involvement of a 
colorectal surgeon 
and/or urologist 
and frequency of sexual intercourse. 
Guzick et al., 2011 (67)  // 12 months of either depot 
leuprolide, 11.25 mg every 
12 weeks with hormonal 
add-back using 
norethindrone acetate 5 mg 
orally daily, or a generic 
monophasic oral 
contraceptive daily 
There were no significant differences between the two groups as regard to sexual satisfaction 
 
Meuleman et al., 2011 
(65) 
Radical  laser CO2 
laparoscopic excision 
of deep infiltrating 
colorectal 
endometriosis, 
combined with 
laparoscopic segmental 
bowel resection and 
reanastomosis 
// The sexual activity questionnaire showed a significant improvement after surgery in sexual 
pleasure, frequency of sexual activity and a significant reduction in discomfort during sexual 
intercourse 
Ceccaroni et al.,2012 (53) Nerve-sparing radical 
excision of pelvic 
endometriosis with 
segmental bowel 
resection (group B) 
versus laparoscopic 
non nerve-sparing 
excision of pelvic 
endometriosis with 
bowel resection (group 
A) 
// No difference were found between the two groups in frequency of sexual intercourses after 
interventions and the rates of patients claiming dyspareunia, psychological distress and 
vaginal dryness. Patients in group A claimed more frequent vaginal bleeding, lowered sexual 
desire. Contrarily, a reduced sexual pleasure/frequency of orgasm was claimed by more 
patients in group B. 
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Author, year Type of surgical 
intervention 
Type of pharmacological 
intervention 
Results (Only sexual outcomes) 
Kössi et al., 2012 (54) Laparoscopic complete 
excision of all pelvic 
endometriotic lesions 
and bowel resection for 
colorectal 
endometriosis 
// 12 months after surgery a significant increase in the sexual satisfaction subscale (P=0.01) was 
observed. A statistically significant  decrease was detected in “painful sexual intercourse”. 
Sexual problems and partner satisfaction scores had not changed significantly. 
Mabrouk et al.,2012 (55) Laparoscopic surgery 
for deep endometriosis: 
complete, nerve 
sparing excision of 
endometriotic lesions 
(intestinal resection or 
nodulectomy). 
Postoperative  
administration of OC 
At 6 months follow-up sexual desire, satisfaction with sex and pelvic problem interference 
with intercourse are significantly improved (P<0.05).  Laparoscopic management of DIE did 
not change significantly the orgasm area of the sexual function (P=0.7) No difference in 
sexual outcomes was observed between patients submitted to intestinal resection or nodule 
excision. 
Setälä et al., 2012 (56) Complete excision of 
endometriotic nodules 
in the posterior fornix 
of the vagina, including 
vaginal resection, by a 
laparoscopic or 
combined 
laparoscopic-vaginal 
approach. 
// 12 months after surgery, the sexual satisfaction score was higher (P =0.03) and the sexual 
problems score lower (P=0.04) compared with baseline values. 
Van den Broeck et al., 
2013 (57) 
Laparoscopic radical 
surgery for 
endometriosis, with or 
without bowel 
resection 
// Overall women in the bowel resection group had better outcomes in the SSFS arousal domain 
For sexual desire, orgasm problems and pain during intercourse no significant differences 
between the two groups were found (P<0.05). 
Vercellini et al., 2013 (68) 51 patients in surgery 
group: attempt to 
remove all 
endometriosis lesions. 
Two patient with 
rectovaginal lesions 
underwent colorectal 
resection 
103 patient in progestin 
group: 
Norethisterone acetate 2.5 
mg per day 
Global sexual function improved immediately in the surgery group, but worsened with time, 
whereas sexual function improved more gradually, but progressive, in the progestin therapy 
group. No significant differences were observed between the two study group at 12 months 
follow-up. A tendency was observed towards a slightly better sexual function after surgery at 
the end of the study period. 
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Author, year Type of surgical 
intervention 
Type of pharmacological 
intervention 
Results (Only sexual outcomes) 
Che at al., 2014 (58) A total of 108 women 
underwent 
conventional 
laparoscopic or 
laparotomic surgery 
(n=63) or nerve- 
sparing surgery (n=45) 
for the treatment of 
DIE 
// The total postoperative FSFI score 24 months after surgery increased significantly in both 
groups, with no between-group difference. When analyzed separately for each FSFI domains, 
both groups showed similar results for desire, arousal, and orgasm and had an elevated score 
immediately after surgery, which almost remained unchanged over time. Differently, pain 
score significantly increase after surgery and dropped over time. For satisfaction FSFI 
domain, the results showed no significant difference at the 24-month follow-up compared 
with the pre-operative assessment. However, the total post-operative FSFI score and the 6 
subdomain scores of the questionnaire were below the cut-off of dysfunction  before and after 
surgery.  
Morotti et al., 2014 (59) // Treatment with dienogest in 
patients who were 
unsatisfied with previous 6 
months norestisterone 
acetate treatment 
Women after 6 months of dienogest treatment showed increased FSFI values compared to 
women at the end of 6 months of noretisterone acetate treatment. Regarding each domain of 
the FSFI questionnaire, a statistical increase was found on lubrication and pain scores 
Di Donato et al., 2015 
(60) 
Complete laparoscopic 
excision of all visible 
endometriotic lesions 
// A significant improvement was found between pre- and post- laparoscopic surgery in the 
desire, satisfaction , and pelvic problem interference with sex scales of the sexual 
questionnaire. At 6 months follow-up the distribution of the SHOW-Q scores was comparable 
to healthy women’s scores, apart for the orgasm score. 
Caruso et al., 2015 (62) // 6-months Dienogest therapy All aspects of the FSFI and FSDS questionnaire significantly improved after 6 months od 2 
mg/daily dienogest therapy, as compared to the control group 
Morelli et al., 2016 (61) Robot-assisted surgery 
for the radical 
treatment of DIE with 
colorectal involvement 
Post-operative OC in all 
cases except for women who 
were trying to conceive 
All aspects of the FSFI questionnaire worsened significantly 1 month after surgery, but 
showed a subsequent progressive increase and 12 months post surgery the scores were 
comparable to those assessed pre-operatively. Dyspareunia was significantly improved 12 
months after surgery with respect to the baseline assessment. 
Vercellini et al., 2016 (69) // 6-months Dienogest therapy A statistically significant increase in total FSFI score was observed in women treated with 
dienogest, with no statistically differences compared with women treated with noretisterone 
acetate. The increase in sexual function was homogenous on the six different subdomain of 
the FSFI. Although, the 6 month total FSFI score remained below the threshold for sexual 
dysfunction 
Fritzer et al., 2016 (63) Laparoscopical radical 
resection of 
endometriosis 
// Pain scores as well as feelings of guilt toward the partner, being afraid of pain and feeling of 
being a burden for the relationship significantly decreased after surgery. 
Abbreviations: OC, oral contraceptives; FSFI: Female Sexual Function Index; DIE: deep infiltrating endometriosis; SSFS: Short sexual functioning scale; FSDS: Female 
Sexual Distress Scale; SHOW-Q: Sexual health Outcomes in Women Questionnaire. 
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Figure 1. Study selection flow chart. 
 
 
 
Total number of records identified 
through database searching  
(n = 615) 
Records excluded by title and/or by 
abstract and duplicates removed 
(n = 555) 
Full-text articles assessed for 
eligibility according to inclusion and 
exclusion criteria 
(n = 60) 
Full-text articles excluded (n = 38): 
 3 were not written in English; 
 11 were review articles or 
commentaries; 
 2 were qualitative studies; 
 14 considered dyspareunia as 
the only sexual outcome and 
measures did not  involve 
comprehensive sexual 
questionnaires or no specific 
information from the 
questionnaires used was 
reported.   
 8 were studies on the impact 
of having endometriosis on 
sexual functioning, without 
considering the effect of any 
medical intervention 
Studies included in the current review  
(n = 22) 
